Treatment of follicular lymphoma with antibody CD20 -CLE 2016 2EME VAGUE (Q3682030): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
(‎Changed label, description and/or aliases in de: translated_label)
label / delabel / de
 
Behandlung von follikulären Lymphomen mit Antikörpern gegen CD20 -CLE 2016 2EME VAGUE

Revision as of 15:02, 26 November 2021

Project Q3682030 in France
Language Label Description Also known as
English
Treatment of follicular lymphoma with antibody CD20 -CLE 2016 2EME VAGUE
Project Q3682030 in France

    Statements

    0 references
    89,537.0 Euro
    0 references
    419,424.0 Euro
    0 references
    21.35 percent
    0 references
    1 January 2017
    0 references
    31 December 2018
    0 references
    Centre National de la Recherche Scientifique
    0 references
    0 references
    Le projet "Traitement des lymphomes folliculaires par des anticorps anti-CD20" a pour objectif le développement d'outils d'imagerie quantitative pour l'évaluation d'efficacité par microscopie à feuille de lumière. (French)
    0 references
    The objective of the project “Treatment of follicular lymphomas with anti-CD20 antibodies” is to develop quantitative imaging tools for the evaluation of effectiveness by light sheet microscopy. (English)
    18 November 2021
    0 references

    Identifiers

    MP0008755
    0 references